|
Group Post |
NIH panel says plasma should not yet be considered standard care for cornonavirus |
mike kraft |
|
Group Post |
All the pros—and cons—of convalescent plasma therapy for COVID-19 |
mike kraft |
|
Group Post |
HHS canceling ventilator contracts, says stockpile is full |
mike kraft |
|
Group Post |
Steroids cut death rates among critically ill COVID-19 patients, major study finds |
mike kraft |
|
Group Post |
Symptoms can last much longer than expected--CDC study |
mike kraft |
|
Group Post |
Why the Coronavirus More Often Strikes Children of Color |
mike kraft |
|
Group Post |
The C.D.C. tells health officials to be ready to distribute a vaccine by November, raising concerns over politicized timing. |
mike kraft |
|
Group Post |
Vaccine group says 76 rich countries now committed to 'COVAX' access plan |
mike kraft |
|
Group Post |
ANALYSIS: Solar Panel Prices have dropped sharply since 2016 |
mike kraft |
|
Group Post |
COVID cluster from Chinese bus trip offers more evidence of airborne transmission |
mike kraft |
|
Group Post |
Debate rages over whether FDA should use emergency powers to clear a coronavirus vaccine early |
mike kraft |
|
Group Post |
Nasal swab followed by antibody test may catch incorrect Covid-19 diagnoses |
mike kraft |
|
Group Post |
Britain aims for virus testing success after a wobbly start |
mike kraft |
|
Group Post |
NIH announced funding for stepped up support for new COVID testing technologies |
mike kraft |
|
Group Post |
Members named to panel probing WHO's pandemic response |
mike kraft |
|
Group Post |
Top Adviser To Operation Warp Speed Calls An October Vaccine 'Extremely Unlikely' |
mike kraft |
|
Group Post |
Mexico has world's most health worker deaths from pandemic, Amnesty International says |
mike kraft |
|
Group Post |
Widespread COVID-19 vaccinations not expected until mid-2021, WHO says |
mike kraft |
|
Group Post |
Results of Russia's COVID-19 vaccine produced antibody response: The Lancet |
mike kraft |
|
Group Post |
Labor Day weekend will set the course for the coronavirus this fall: ‘We may have some hard days ahead’ |
mike kraft |
|
Group Post |
Roche to offer SARS-CoV-2 rapid antigen test to CE Mark accepting countries, apply for EUA |
mike kraft |
|
Group Post |
Delivering super-cooled COVID-19 vaccine a daunting challenge for some countries |
mike kraft |
|
Group Post |
Trump Administration Will Redirect $62 Million Owed to the W.H.O. |
mike kraft |
|
Group Post |
Pharma Companies Plan Joint Pledge on Vaccine Safety |
mike kraft |
|
Group Post |
U.S. coronavirus deaths projected to more than double to 410,000 by January |
mike kraft |
Recent Comments